Caribou Biosciences, Inc.
USD1.78
+0.01 (+0.56%)
CEO
Rachel E. Haurwitz
IPO Date
2021-07-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$1.81
Prev. Close
$1.77
Day Low
$1.75
Day High
$1.81
52W Low
$1.22
52W High
$3.54
Market Cap
$0.18B
Volume
0.27M
| -1.0 |
| 31 Dec 2023 | FY | 89.8% | -296.1% | -27.7% | -23.6% | 0.07 | 11.97 | -4.1 |
| 31 Dec 2022 | FY | 73.7% | -717.8% | -33.0% | -26.6% | 0.09 | 9.25 | -3.8 |
| 31 Dec 2021 | FY | 89.7% | -697.3% | -17.3% | -15.1% | 0.00 | 15.15 | -13.6 |
| 31 Dec 2020 | FY | -178.5% | -277.6% | 146.4% | -95.2% | -0.07 | 1.96 | -13.2 |
| 31 Dec 2019 | FY | 100.0% | -404.8% | -314.0% | -37.8% | 0.07 | 5.66 | -19.3 |
| -1.4 |
| 30 Sept 2025 | Q3 | 100.0% | -1253.3% | -19.4% | -14.1% | 0.18 | 5.54 | -2.0 |
| 30 Jun 2025 | Q2 | 100.0% | -2028.4% | -32.6% | -24.5% | 0.16 | 6.66 | -0.5 |
| 31 Mar 2025 | Q1 | 100.0% | -1699.6% | -18.4% | -14.6% | 0.12 | 7.63 | -0.5 |
| 31 Dec 2024 | Q4 | -1337.8% | -1708.7% | -14.0% | -11.3% | 0.10 | 7.16 | -1.0 |
| 30 Sept 2024 | Q3 | 100.0% | -1713.6% | -12.3% | -10.1% | 0.10 | 7.38 | -1.3 |
| 30 Jun 2024 | Q2 | 75.3% | -1088.3% | -12.1% | -10.1% | 0.09 | 8.75 | -1.0 |
| 31 Mar 2024 | Q1 | 70.8% | -1697.6% | -12.0% | -10.1% | 0.08 | 10.49 | -2.7 |
| 31 Dec 2023 | Q4 | 44.5% | -969.8% | -9.4% | -8.0% | 0.07 | 11.97 | -3.7 |